现在已经批准的疫苗里中国两个。 https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html lter the list of vaccines: All vaccines Preclinical Phase 1 Phase 2 Phase 3 Approved PHASE 3 APPROVED FOR LIMITED USE IN CHINA The Chinese company CanSino Biologics developed a vaccine based on an adenovirus called Ad5, in partnership with the Institute of Biology at the country’s Academy of Military Medical Sciences. In May, they published promising results from a Phase 1 safety trial, and in July they reported that their Phase 2 trials demonstrated the vaccine produced a strong immune response. In an unprecedented move, the Chinese military approved the vaccine on June 25 for a year as a “specially needed drug.” CanSino would not say whether vaccination would be mandatory or optional for soldiers. Starting in August, CanSino began running Phase 3 trials in a number of countries, including Saudi Arabia, Pakistan and Russia. Updated Sept. 24 PHASE 3 APPROVED FOR EARLY USE IN RUSSIA The Gamaleya Research Institute, part of Russia’s Ministry of Health, launched clinical trials in June of a vaccine they called Gam-Covid-Vac. It is a combination of two adenoviruses, Ad5 and Ad26, both engineered with a coronavirus gene. On Aug. 11, President Vladimir V. Putin announced that a Russian health care regulator had approved the vaccine, renamed Sputnik V, before Phase 3 trials had even begun. Vaccine experts decried the move as risky, and Russia later walked back the announcement, saying that the approval was a “conditional registration certificate,” which would depend on positive results from Phase 3 trials. Those trials, initially planned for just 2,000 volunteers, were expanded to 40,000. In addition to Russia, volunteers were recruited in Belarus, the United Arab Emirates, and Venezuela. On Oct. 17, a Phase 2/3 trial was launched in India. On Sept. 4, three weeks after Putin’s announcement, Gamaleya researchers published the results of their Phase 1/2 trial. In a small study, they found that Sputnik yielded antibodies to the coronavirus and mild side effects. Meanwhile, Russia negotiated agreements to supply the vaccine to countries including Argentina, Brazil, Mexico and India. On Nov. 11, the Russian Direct Investment Fund announced preliminary evidence from their Phase 3 trial indicating that the vaccine is effective. Based on 20 cases of Covid-19 among the trial participants, Russian scientists estimated that the vaccine demonstrated 92 percent efficacy. Outside experts said that was possible, but they also said that data from more cases would be needed to see if that estimate held up. In their press release, the fund said that the results of the trial would be eventually published in a peer-reviewed scientific journal. The announcement came two days after Pfizer announced similar results on 94 volunteers in its own Phase 3 trial. Updated Nov. 19 PHASE 1 PHASE 2 COMBINED PHASES APPROVED FOR EARLY USE IN RUSSIA On Aug. 26, the Vector Institute, a Russian biological research center, registered a Phase 1/2 trial for a coronavirus vaccine they call EpiVacCorona. The vaccine contains small portions of viral proteins, known as peptides. According to newspaper reports, the EpiVacCorona trials had already begun by then. On October 14, Vladimir Putin announced that Russia has granted regulatory approval to EpiVacCorona, making it the second vaccine to receive that designation after the Gamelaya Institute’s Sputnik V vaccine. Like the Sputnik vaccine, EpiVacCorona received approval before a Phase 3 trial to demonstrate that it was safe and effective. That trial is expected to start later this year. Updated Oct. 14 PHASE 3 APPROVED FOR LIMITED USE IN U.A.E. The Wuhan Institute of Biological Products developed an inactivated virus vaccine, which the state-owned Chinese company Sinopharm put into clinical tests. The Phase 1/2 trial showed that the vaccine produced antibodies in volunteers, some of whom experienced fevers and other side effects. They Phase 3 trials in the United Arab Emirates in July, and in Morocco and Peru the following month. Over the summer, the company later said, the Chinese government gave it approval to inject the Wuhan vaccine as well as a second candidate from the Beijing Institute of Biological Products into government officials, health care workers, and other select groups. By November, the chairman of Sinopharm said, almost a million people in China had received the vaccines. . On Sept. 14, the U.A.E. gave emergency approval for Sinopharm’s vaccine to use on health care workers, and soon government officials and others were also receiving it. Yet Sinopharm has yet to publish Phase 3 data on either vaccine to demonstrate that they are safe and effective. Updated Nov. 20 PHASE 3 APPROVED FOR LIMITED USE IN U.A.E. In addition to their Wuhan vaccine, Sinopharm also began testing an inactivated virus vaccine developed by the Beijing Institute of Biological Products. After running early clinical trials in China, they launched Phase 3 trials in the United Arab Emirates and Argentina. In October, the chairman of Sinopharm said the company was gearing up manufacturing for their two vaccines, with plans for producing a billion doses a year. Updated Nov. 20 PHASE 3 APPROVED FOR LIMITED USE IN CHINA Sinovac Biotech, a private Chinese company, developed an inactivated vaccine called CoronaVac. In June the company announced that Phase 1/2 trials on 743 volunteers found no severe adverse effects and produced an immune response. Sinovac published the details of the trial in November in a medical journal, showing a comparatively modest production of antibodies. Only a Phase 3 trial would demonstrate if that was enough to protect people from Covid-19. In July, Sinovac launched a Phase 3 trial in Brazil, followed by others in Indonesia and Turkey. While Sinovac has yet to release late-stage trial data, on Oct. 19 officials in Brazil said that it was the safest of five vaccines they were testing in Phase 3 trials. Reuters reported that the Chinese government gave the Sinovac vaccine an emergency approval for limited use in July. In October, authorities in the eastern Chinese city of Jiaxing announced they were giving CoronVac to people in relatively high-risk jobs, including medical workers, port inspectors and public service personnel. Meanwhile, Sinovac has been preparing to manufacture the vaccine for global distribution, reaching an agreement to supply Indonesia with at least 40 million doses by March 2021. In September, Yin Weidong, the CEO of Sinovac, said the company planned on worldwide distribution of the vaccine in early 2021 — including the United States. On Nov. 9, the Brazilian government announced they had paused the country’s Sinovac trial the previous month because of an adverse event. The details of the pause were murky, raising suspicions that politics were involved. Two days after the announcement, the trial was allowed to resume. Updated Nov. 20
🔥 最新回帖
迟早要进口的。
基本上那些喜欢扣帽子的主儿,就是自个儿没能力以理服人而已。要是真的能把正理儿说的大家都一看就明白,觉得“这说的太对了”,他们还用的着去扣帽子么?
简单点儿说,大家来这儿,就是为了斗嘴的。看的就是谁有本事把自个儿的理儿说清说透。至于对方究竟就是一般人,还是翻墙的,是五毛。是美分,是无间道,有关系么?非要给对方扣帽子的话,咱这么说吧,如果一个人连翻墙的,五毛,美分都说不过,是不是自个儿能力也太差了?
🛋️ 沙发板凳
复星不也是从德国进口吗???
国内一般不敢报道德国这个公司啊
感觉有点丢人啊
天津刚社区感染了,希望尽快控制住吧…
为什么啊?复兴到底负责什么的?和这个德国公司合作, 比如辉瑞是生产对吧?那么复兴呢?
复兴是德国公司授权的唯一亚州生产商。
只做不说,不报道就行了,宣传口一个口头通知的事儿
复星就是大中华区代理销售,初期从德国进口疫苗,Biontech不排除后期在中国建厂。
啥亚洲啊?就是大中华区的销售代理。
韭菜也不是傻子啊,有疫苗了还大规模封城?
大家是不是已经忘了国内假疫苗的事了。
美国华人可以积极参与高大上 早死早托生
除非国内永远保持入境隔离14天政策
怎么可能一样好呢?中国自称100%有效还没有副作用国外最好的也就95%有效加上一大堆副作用。
国产疫苗两针1000rmb, 这两个mRNA疫苗在美国都远远比这个价格便宜。
中国疫苗100%,比百分之九十几的外国疫苗好。
就算進口
也得磨皮
一个意思啊,进口德国的已经板上钉钉,那怎么会不进口美国的呢?
好奇,如果按照报道,国内早就清0, 回国人都隔离也清零。 那现在的1234和更多是哪里来的?
现在通常是甩锅进口冷链,墙内屁民都义愤填膺武汉病毒也来自进口冷链!!!
来自境外的人、鱼、肉、行李...
你气死还差不多 你整天在北美华人网恨国恨国的 莫不是脑子有问题?
咽不下这口气的是国内的人吧,我有个群她们平时给自己给小孩都是打进口疫苗的,这次德国疫苗好消息出来她们绝口不提然后国药的新闻一个劲转还说快了快了有疫苗了,我倒是要看看她们到底打哪种,为了爱国良心都不要了
环球时报读多了得出的结论?
一 这里是北美华人论坛。 二 说到仇恨,中国人以及在美国的小粉红对美国的仇恨,想必大家也是看在眼里。 三 满嘴爱国的,如果你说的那个国是中国。那么我送你一句话,你也配姓赵。
都是轮子在意淫。
不要问,问就是与某党对着干。小心被嫖娼被贪污。
这里是美国,除了翻墙的货基本都是美国人,恨国?恨什么国?最恨华人的不就是你们这些粉红五毛战狼
要实事求是。
隔离人员没有清零,有超过14天才阳的,还有冷链行李之类的。国内清零也不是全部普测之后的清零,只是没有新病例报告,可能有无症状长阳的,概率比较小而已。
多少年没回中国的感觉,现在还这样吗?
不是你们这种id天天来带风向,现在倒打一耙了?
不买进口货,给国家省外汇,也是除了自杀以外,韭菜能为你的国做的贡献之一了。
这是她能选的吗,真是搞笑。我还有个朋友说,到时候哪个便宜用哪个呗。这都是啥脑子,再便宜也不如人民币能买到的便宜啊。
现在已经批准的疫苗里中国两个。 https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
lter the list of vaccines: All vaccines Preclinical Phase 1 Phase 2 Phase 3 Approved PHASE 3 APPROVED FOR LIMITED USE IN CHINA The Chinese company CanSino Biologics developed a vaccine based on an adenovirus called Ad5, in partnership with the Institute of Biology at the country’s Academy of Military Medical Sciences. In May, they published promising results from a Phase 1 safety trial, and in July they reported that their Phase 2 trials demonstrated the vaccine produced a strong immune response. In an unprecedented move, the Chinese military approved the vaccine on June 25 for a year as a “specially needed drug.” CanSino would not say whether vaccination would be mandatory or optional for soldiers. Starting in August, CanSino began running Phase 3 trials in a number of countries, including Saudi Arabia, Pakistan and Russia. Updated Sept. 24 PHASE 3 APPROVED FOR EARLY USE IN RUSSIA The Gamaleya Research Institute, part of Russia’s Ministry of Health, launched clinical trials in June of a vaccine they called Gam-Covid-Vac. It is a combination of two adenoviruses, Ad5 and Ad26, both engineered with a coronavirus gene.
On Aug. 11, President Vladimir V. Putin announced that a Russian health care regulator had approved the vaccine, renamed Sputnik V, before Phase 3 trials had even begun. Vaccine experts decried the move as risky, and Russia later walked back the announcement, saying that the approval was a “conditional registration certificate,” which would depend on positive results from Phase 3 trials. Those trials, initially planned for just 2,000 volunteers, were expanded to 40,000. In addition to Russia, volunteers were recruited in Belarus, the United Arab Emirates, and Venezuela. On Oct. 17, a Phase 2/3 trial was launched in India.
On Sept. 4, three weeks after Putin’s announcement, Gamaleya researchers published the results of their Phase 1/2 trial. In a small study, they found that Sputnik yielded antibodies to the coronavirus and mild side effects. Meanwhile, Russia negotiated agreements to supply the vaccine to countries including Argentina, Brazil, Mexico and India.
On Nov. 11, the Russian Direct Investment Fund announced preliminary evidence from their Phase 3 trial indicating that the vaccine is effective. Based on 20 cases of Covid-19 among the trial participants, Russian scientists estimated that the vaccine demonstrated 92 percent efficacy. Outside experts said that was possible, but they also said that data from more cases would be needed to see if that estimate held up. In their press release, the fund said that the results of the trial would be eventually published in a peer-reviewed scientific journal. The announcement came two days after Pfizer announced similar results on 94 volunteers in its own Phase 3 trial. Updated Nov. 19 PHASE 1 PHASE 2 COMBINED PHASES APPROVED FOR EARLY USE IN RUSSIA On Aug. 26, the Vector Institute, a Russian biological research center, registered a Phase 1/2 trial for a coronavirus vaccine they call EpiVacCorona. The vaccine contains small portions of viral proteins, known as peptides. According to newspaper reports, the EpiVacCorona trials had already begun by then. On October 14, Vladimir Putin announced that Russia has granted regulatory approval to EpiVacCorona, making it the second vaccine to receive that designation after the Gamelaya Institute’s Sputnik V vaccine. Like the Sputnik vaccine, EpiVacCorona received approval before a Phase 3 trial to demonstrate that it was safe and effective. That trial is expected to start later this year. Updated Oct. 14 PHASE 3 APPROVED FOR LIMITED USE IN U.A.E. The Wuhan Institute of Biological Products developed an inactivated virus vaccine, which the state-owned Chinese company Sinopharm put into clinical tests. The Phase 1/2 trial showed that the vaccine produced antibodies in volunteers, some of whom experienced fevers and other side effects. They Phase 3 trials in the United Arab Emirates in July, and in Morocco and Peru the following month. Over the summer, the company later said, the Chinese government gave it approval to inject the Wuhan vaccine as well as a second candidate from the Beijing Institute of Biological Products into government officials, health care workers, and other select groups. By November, the chairman of Sinopharm said, almost a million people in China had received the vaccines. . On Sept. 14, the U.A.E. gave emergency approval for Sinopharm’s vaccine to use on health care workers, and soon government officials and others were also receiving it. Yet Sinopharm has yet to publish Phase 3 data on either vaccine to demonstrate that they are safe and effective. Updated Nov. 20 PHASE 3 APPROVED FOR LIMITED USE IN U.A.E. In addition to their Wuhan vaccine, Sinopharm also began testing an inactivated virus vaccine developed by the Beijing Institute of Biological Products. After running early clinical trials in China, they launched Phase 3 trials in the United Arab Emirates and Argentina. In October, the chairman of Sinopharm said the company was gearing up manufacturing for their two vaccines, with plans for producing a billion doses a year. Updated Nov. 20 PHASE 3 APPROVED FOR LIMITED USE IN CHINA Sinovac Biotech, a private Chinese company, developed an inactivated vaccine called CoronaVac. In June the company announced that Phase 1/2 trials on 743 volunteers found no severe adverse effects and produced an immune response. Sinovac published the details of the trial in November in a medical journal, showing a comparatively modest production of antibodies. Only a Phase 3 trial would demonstrate if that was enough to protect people from Covid-19.
In July, Sinovac launched a Phase 3 trial in Brazil, followed by others in Indonesia and Turkey. While Sinovac has yet to release late-stage trial data, on Oct. 19 officials in Brazil said that it was the safest of five vaccines they were testing in Phase 3 trials.
Reuters reported that the Chinese government gave the Sinovac vaccine an emergency approval for limited use in July. In October, authorities in the eastern Chinese city of Jiaxing announced they were giving CoronVac to people in relatively high-risk jobs, including medical workers, port inspectors and public service personnel.
Meanwhile, Sinovac has been preparing to manufacture the vaccine for global distribution, reaching an agreement to supply Indonesia with at least 40 million doses by March 2021. In September, Yin Weidong, the CEO of Sinovac, said the company planned on worldwide distribution of the vaccine in early 2021 — including the United States.
On Nov. 9, the Brazilian government announced they had paused the country’s Sinovac trial the previous month because of an adverse event. The details of the pause were murky, raising suspicions that politics were involved. Two days after the announcement, the trial was allowed to resume. Updated Nov. 20
一:这是哪儿的论坛和楼上说的有半分钱关系么?她说“你们这些恨国党”,有点儿理解能力的都知道她这个“国”说的是中国,没说是你们这些人现在所属的国家。 二:您咋就那么大能力,张嘴就认定中国人对美国仇恨呢?有几个中国人对美国仇恨就成了中国人对美国仇恨?那咋不说有人对美国仇恨就是“人对美国仇恨”呢? 三:人家完全没提爱国,只是说“你们这些恨国党”而已。她自己可以爱国,可以不爱国,甚至也可以和“你们这些恨国党”同一党。您就别这儿睁眼说瞎话了。
你可以说你们这些恨中国党。这里是北美论坛,我们没有爱中国的义务。
在任何地方的论坛的人都没有爱中国的义务。
楼上也没要大家爱中国,她只是指出她认为某些人是“恨国党”而已。恨和不爱,还是有很大差别的。
当然,她是不是说对了,这个是另外一个问题。
lz你真low,就跟个洞里的老鼠似的。
因为还没到冬天吧,国内专家也说了冬天会比较麻烦,双阴这些应该都是因应的政策调整。
估计拉不下脸来进口美国的吧,反正BNTX自己也要搞生产线,可以从德国进口
建议交给长春长生来生产,绝对快。很快1B人就都打上了。
哈哈哈,你真天真。药厂投这么多钱做研发是为了做慈善吗?知识产权不值钱没人再费劲研发新药,大家都没有新药用了
🐂!如果是长春长生来生产,配方都不需要😂
兄弟,你配姓白,姓川还是姓拜?在国内再怎么不配还同是一个人种,你这跑美国去就是个外来种,连黑鬼都能欺你,你哪来的底气高高在上优人一等?这论坛整天反中的和你都是一个德行!美国一天都十几万确诊的报还有脸舔!反中都反成智障了。
脑子有问题的是你吧。回去看看自己的子女是否性格跟你一样偏执?
北朝鲜病例更少,也没挡住中国人民三胖三胖的嘲笑他们。这后面的道理和这里的人嘲笑中国是一样的。 你说什么?行了行了,全世界都知道你们和北朝鲜人民一样,都觉得自己是最幸福的。没问题,你自己开心就好。多享受你的幸福生活吧,别翻墙出来找不痛快了。小心给抓起来。
我高人一等?哪里看出来的?你们这些墙里出来的人每天心里想的就是谁比自己高谁比自己低吗?你们到底有多自卑?
华人本来就是个大妈闲聊家常的网站,你们这些墙里人跑过来天天发些乱七八糟的东西,进行人身攻击,然后现在倒打一耙啊。你们要不要脸?
我不觉得我高人一等,但是比起那些不要脸的连人都不算的玩意,肯定是要高一些的。我来美国十几年,认认真真学习,踏踏实实工作。我交的税,town里都清清楚楚的告诉我花在哪里。我对社会对国家不满意,可以给议员写信,可以给自己组织抗议。我刚到美国的时候,人生地不熟,受到过很多善良人的帮助。我参加学校的pta,为华人孩子发声。这个国家不完美,有很多不好的地方。但是,我对这个国家有认同感,我觉得我是这个国家的一份子,我爱这个国家。
这些普普通通的平凡感情,是你们这些翻墙过来挑事骂街的人感受不到的。你们的心里,只有等级制度,每天想着不跌落下去,怎么去努力满足领导的要求。你们所追求的目标,就是一个“活着”而已。一个正常公民所拥有的权利,你拥有哪一个?只会津津乐道主人今天给的泔水是如何的鲜美,猪圈是如何的安全。
你这种满嘴脏话的东西,不配得到别人的愤怒,只配得到我的蔑视。你这种,既不爱国,也不爱党,更不爱家庭。一个为了活着放弃尊严下限的人,说出什么话做出什么事都是可能的。今天翻墙来挑事,赶明儿就可以毫无心理压力的去给美军带路顺便去入室抢劫。变形虫一样。
同好奇。这需要花时间吧?
1: 既然是北美华人论坛,又觉得自己是骄傲的美国人,就多关心美国的事,这种中国疫苗用谁的和你毛关系都 没有,都不知道进这个帖子干嘛,有脸说别人翻墙,自己在墙外整天唠叨墙内的事是啥情况。 2: 墙内人没资格发言这种说法在这个论坛不是一年两年了,这种在疫情前是歧视,疫情后喊这种话状态都歇斯底 里了。是什么心态大家自己品。美国人对中国人的仇恨其实远不如在美国的某些华人对中国居然能缓过来的仇 恨。现在说到美国的疫情都是造谣,都是恨美国,原来北大一女生寝室里共用电脑能把同屋的offer给悄悄删了 这种心态基本是一种。 3: 别人爱国不一定基于得到利益,但你爱国显然觉得要得到利益,有些毒,有些人觉得到了墙外自己解毒了,问 题怎么证明自己不是被毒上加毒了?
人吧,多照照镜子看看自己的想法是否就代表正确这是正常人基本因该努力达到的修养,别老想着教训别人,更别觉得自己到了某个地域就因此高人一等,还是那句话,美国的繁荣你也就是来坐享其成,别人的血泪建设的时候你还是个墙内的精子呢。
没人逼着你爱啊,除了爱和恨还有中立客观吧。做不到中立客观哪里都一样被骂。
说实话,一个能靠自己工作生活幸福的人,看到的世界都是阳光的一面,自己有病还是要看医生,不要怪环境。
你怎么就知道我是翻墙呢。我一直挺纳闷,怎么论坛好多人都是千里眼,只要不说中国坏,一定是翻墙和廊坊的。 最近几天这个趋势又有点抬头
看见你的第一句话,就不需要下看了。对不起,我从来不因为自己是美国人而骄傲。但是我庆幸自己是个有自尊的人,这和国籍无关。翻墙出来给ccp唱赞歌挑事的人,其无耻也不是因为身为中国人,而是因为他们合理化强权和压迫。
你们生活怎样,我不关心。但是,病毒从哪里来的?一开始是谁封锁消息的?是谁大开国门让病毒传播到全世界的?是谁满到处胡说八道泼脏水的?是谁一边吹牛一边不让自己的国民回国的?这几个问题的答案,你自己心里没数吗?
你们自己什么样,真的从来不照镜子吗?
必须手动给你点赞,姐们儿看来跟我一样对五毛猖獗的现象忍了很久了
真的,我今年最讨厌就是五毛粉红战狼。恶心坏了🤮
手动点赞👍
黨國分立
愛國 所以恨黨
應該是 恨黨愛國
肯定的,国内有钱人都迷信欧美疫苗,可以卖高价
没有疫苗,没法恢复国际交流
-80的冷鍊還不能用郵寄的
得專門找
有-80冷鍊的飛機
赞👍
把火方倉送過去吧
愛用不用
请问什么叫给CCP唱赞歌了,有谁提到CCP了?是不是只要说句中国好的方面都叫给CCP唱赞歌,这么大的国家,哪一个不是有好的一面有坏的的一面?从疫情到现在,唯一笃定病毒是中国起源的,就是法轮功媒体,请问你找出哪一个权威科学杂志现在给出病毒从哪里来的证据?或者您本身就是FLG媒体?就算病毒是先在中国爆发,中国也是受害者,只不过先恢复过来了,你要说大开国门传播病毒,请问美国现在有因为自己感染人数全世界第一有觉得担心传播别人停掉出国的航班吗?要说中国大开国门传播病毒,中国不让自己的国民回国,是中国政府做的不对,中国的人民会去投诉,但管你一个美国人屁事,让中国人回去也没有你这种人的份。告诉你,大家心里都有数,不要以为去给别人泼污水自己就变道德高尚了,你有本事现在去给你们参议院写信要求美国自封国门不要出去散播病毒高尚一把。这次疫情真是一面镜子,照出你们心里极度龌蹉的一帮假洋鬼子。
作为旁观者,您嘴里的“你们”肯定有他们的问题,但您也不像您自个儿说的那么“高一些”。至少,您的逻辑是极端混乱的。
首先,请您搞清楚,大家在这里都是个体,只为自己的行为/言论负责。您张嘴就“你们这些墙里人跑过来天天发些乱七八糟的东西,进行人身攻击”,请问您回帖的对象做这些事了么?您拿别人做的事,套在对方头上,定义其为“你们”,这可笑不可笑?我能把某杀人犯做的事批驳一番,然后把您和他也定义成你们,于是您就要为杀人犯的行为负责么?
其次,您一开篇就讽刺别人“每天心里想的就是谁比自己高谁比自己低吗?你们到底有多自卑”,可见您是号称觉得不该去比谁高谁低。但您后面好像忘了自己对“心里想的就是谁比自己高谁比自己低”的不屑,张嘴就说自己“比起那些不要脸的连人都不算的玩意,肯定是要高一些的”。您这自相矛盾的很逗啊?
第三,也是某些同学(这里我不用“你们”哦)常常在这里做的事:不是因为对方本身的行为有什么错而攻击对方,而是因为对方外在条件不好,而极进攻击讽刺之能事。就算对方真在“墙内”,真的没有啥“正常公民所拥有的权利”,这是对方的错么?您拿不是对方自己的错去讽刺对方,您也真是有脸啊。。。
最后,您指责对方满嘴脏话,您自个儿呢?骂人“不要脸的连人都不算”,骂人变形虫,您倒是不“满嘴脏话”,只是说几句而已,是吧?
这个驳的很好啊。 但是对一些人其实没什么用,一会等那些人上班了,马上给你扣帽子:翻墙的。
看一些帖子有一定的规律的,一些人一上班,前呼后拥的就来灌水了,灌得帖子不能看就达到目的了。
基本上那些喜欢扣帽子的主儿,就是自个儿没能力以理服人而已。要是真的能把正理儿说的大家都一看就明白,觉得“这说的太对了”,他们还用的着去扣帽子么?
简单点儿说,大家来这儿,就是为了斗嘴的。看的就是谁有本事把自个儿的理儿说清说透。至于对方究竟就是一般人,还是翻墙的,是五毛。是美分,是无间道,有关系么?非要给对方扣帽子的话,咱这么说吧,如果一个人连翻墙的,五毛,美分都说不过,是不是自个儿能力也太差了?
迟早要进口的。